M1171 – Patient received at least one td vaccine or one tdap vaccine between nine years prior to the encounter and the end of the measurement period

Long description

Patient received at least one td vaccine or one tdap vaccine between nine years prior to the encounter and the end of the measurement period

Short description

Pt recd 1 td/tdap 9yrs prior

Pricing indicator

00 Not separately priced by Part B (bundled, not covered or Part A only)

Medicare coverage

C Carrier judgment – coverage decided by the Medicare contractor

BETOS category

Z2 Undefined codes

Added

January 1, 2023

Last change

January 1, 2023 – No change

Nearby M codes

• M1163 – Patient had anaphylaxis due to the hpv vaccine any time on or before the patient's 13th birthday
• M1164 – Patients with dementia any time during the patient's history through the end of the measurement period
• M1165 – Patients who use hospice services any time during the measurement period
• M1166 – Pathology report for tissue specimens produced from wide local excisions or re-excisions
• M1167 – In hospice or using hospice services during the measurement period
• M1168 – Patient received an influenza vaccine on or between july 1 of the year prior to the measurement period and june 30 of the measurement period
• M1169 – Documentation of medical reason(s) for not administering influenza vaccine (e.g., prior anaphylaxis due to the influenza vaccine)
• M1170 – Patient did not receive an influenza vaccine on or between july 1 of the year prior to the measurement period and june 30 of the measurement period
• M1172 – Documentation of medical reason(s) for not administering td or tdap vaccine (e.g., prior anaphylaxis due to the td or tdap vaccine or history of encephalopathy within seven days after a previous dose of a td-containing vaccine)
• M1173 – Patient did not receive at least one td vaccine or one tdap vaccine between nine years prior to the encounter and the end of the measurement period
• M1174 – Patient received at least two doses of the herpes zoster recombinant vaccine (at least 28 days apart) on october 20, 2017, through the end of the measurement period
• M1175 – Documentation of medical reason(s) for not administering zoster vaccine (e.g., prior anaphylaxis due to the zoster vaccine)
• M1176 – Patient did not receive two doses of the herpes zoster recombinant vaccine (at least 28 days apart) on october 20, 2017, through the end of the measurement period
• M1177 – Patient received any pneumococcal conjugate or polysaccharide vaccine on or after their 19th birthday and before the end of the measurement period
• M1178 – Documentation of medical reason(s) for not administering pneumococcal vaccine (e.g., prior anaphylaxis due to the pneumococcal vaccine)
• M1179 – Patient did not receive any pneumococcal conjugate or polysaccharide vaccine, on or after their 19th birthday and before or during measurement period